NIH-funded research R01 grant

Does short-term inflammation increase anger and aggression?

Official title: Inflammatory Challenge in Human Aggression

Funded at Ohio State University · NIH-11309150 · Data updated 2026-11-12

Researchers will give a mild, short-lived immune challenge to people with and without histories of aggression to find out if inflammation makes anger and aggressive behavior worse.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startJuly 11, 2024
Project endMarch 31, 2029
Funding year2026
Award (this year)$790,024
NIH project number5R01MH133925-03
Project IDNIH-11309150 on NIH RePORTER

Who could benefit from this research

Could help

Adults diagnosed with mood, anxiety, stress-related, or personality disorders who meet criteria for either high lifetime aggression (e.g., high LHA score and frequent anger attacks) or low lifetime aggression are the intended participants.

Less likely to help

People without those psychiatric diagnoses, children, pregnant people, or individuals with medical conditions that make endotoxin administration unsafe would not be eligible and are unlikely to benefit directly from participating.

What this research studies

You would come to Ohio State for two sessions where, in random order and without knowing which you receive, you get a low-dose endotoxin or a placebo. During and after each session you would have blood draws to measure inflammatory signals, complete self-report anger and mood questionnaires, and take part in behavioral tasks that measure aggressive responding. The study compares people who have a history of frequent aggressive episodes with similar people who have low lifetime aggression to see if the inflammatory challenge changes anger, hostile thinking, or aggressive actions more in one group. Sessions require monitoring for several hours so staff can track physical and emotional responses.

Why it matters

Potential benefit: If successful, this could point to inflammation as a treatable contributor to anger and aggression, guiding new therapies or prevention strategies.

How similar studies have gone: Animal experiments and human studies linking high inflammatory markers to aggression exist, but deliberately provoking short-term inflammation to test causal effects on human aggression is a novel approach.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Coccaro, Emil Frank — Ohio State University
  • Study coordinator: Coccaro, Emil Frank

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.